|
KMID : 1200820080070050466
|
|
Oriental Pharmacy and Experimental Medicine
2008 Volume.7 No. 5 p.466 ~ p.476
|
|
|
Triticum aestivum (Wheatgrass) formulation: An alternate treatment for the patients with Thalassemia
|
|
Desai TR
Solanki JK
Buch Pankaj
Goyal RK
|
|
|
Abstract
|
|
|
|
We have developed the tablet formulation of Triticum aestivum (wheatgrass) and investigated clinically, its effects in patients suffering from b-thalassemia (major) at K. T. Children Hospital, Civil Hospital, Rajkot. The tablets (wheatgrass powder 250 mg.) were given 3 times in a day for 9 months. Blood samples were collected at the start, after 6 months and 9 months and analyzed for various biochemical and hematological parameters. Treatment with wheatgrass formulation for 9 months produced significant decrease in hemoglobin, total RBC, eosinophil and reticulocyte counts. The mean corpuscular volume (MCV) and mean corpuscular hemoglobin concentration (MCHC) were significantly increased was significantly increased. The serum ferritin was also significantly decreased. There was no influence on serum magnesium, serum iron and Thiobarbituric acid reacting substances (TBARS). Our data indicate that treatment with wheatgrass on patients with -thalassemia (major) may have beneficial effects in the form of a decrease in ineffective erythropoiesis, stimulation of hemoglobin synthesis in RBC, decrease in iron load and decrease in eosinophil count.
|
|
|
KEYWORD
|
|
|
Triticum aestivum, Wheatgrass tablets, Thalassemia, Clinical trial
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|